UK CDMO Sterling Pharma Solutions acquires US facility

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/NicoElNino)
(Image: Getty/NicoElNino)

Related tags: CDMO, Sterling Pharma Solutions, Manufacturing

With 70% of its customers in North America and demand increasing, the UK-based CDMO Sterling Pharma Solutions has acquired CiVentiChem’s US facility in Cary, North Carolina.

“Over the last two years we have seen an increasing demand for our services from customers in the US, as well as recognizing the huge potential for future growth in the North American market,”​ said Andrew Henderson, sales and marketing director at Sterling Pharma Solutions.

According to the contract development and manufacturing organization (CDMO) – which was acquired by GHO Capital earlier this year – the North American market makes up 70% of its customer portfolio.

“The decision to acquire was driven by this demand and our desire to be able to offer our customers access to a local team,”​ Henderson added.

The new facility is located close to the Research Triangle Park in North Carolina and will be able to cater to smaller volumes, Henderson said, “Adding the facility to our portfolio gives us a solid platform to pursue our business ambitions.”

Since 2016, Sterling has more than doubled its sales after a management buy-out, according to the CDMO. 

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars